ZYIL1: Clinical Trials

2 trials of ZYIL1, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow ZYIL1: new trials by email Literature Review of ZYIL1 trials Research Report on ZYIL1

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZYIL1 in Patients With Amyotrophic Lateral Sclerosis
ZYIL1 capsules 25 mg and 50 mg Placebo, ZYIL1 capsules 50 mg and 25 mg Placebo, ZYIL1 capsules 25 mg and ZYIL1 capsules 50 mg - Amyotrophic Lateral Sclerosis
Phase 2CompletedZydus Lifesciences Limited242023-11-092024-12-19
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS)
ZYIL1 capsule - Cryopyrin Associated Periodic Syndrome
Phase 2CompletedZydus Lifesciences Limited32022-06-012022-07-11

Conditions studied

Amyotrophic Lateral Sclerosis (1)  ·  Cryopyrin-Associated Periodic Syndromes (1)

Sponsors

Zydus Lifesciences Limited (2)

Countries

Australia (1)  ·  India (1)

Top investigators

Dr Deven Parmar, MD (1)  ·  Dr. Deven Parmar, MD,FCP (1)

Results publications

PMID 40511876